Notably, decreased levels of VEGFR1 were observed in the parietal cortex of AD patients and in the brains of 10- to 11-month-old APP/PS1 mice, suggesting an imbalance toward VEGFR2-mediated effects in the brain parenchyma of AD [11, 23]. The gene discussed is APP; the disease is Alzheimer disease.